ArticleScientific reports2026

Prognostic impact of sarcopenia and blood biomarkers in advanced non-small cell lung cancer on first-line immune checkpoint inhibitors.

Jieun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.